Industry: Pharmaceuticals, Biotechnology
Ranking:
Russell 3000
Tercica, Inc. is a biopharmaceutical company focused on the development and commercialization of products to improve endocrine health. The company’s first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the long-term treatment of severe Primary IGFD. ( www.tercica.com )
Tercica , Inc.
2000 Sierra Point Parkway Suite 400
Brisbane, California 94005
USA
Tel: (650) 624-4900
Fax: (650) 624-4940